Albert David Limited (NSE:ALBERTDAVD)

Market Cap	4.38B
Revenue (ttm)	3.16B
Net Income (ttm)	-150.80M
Shares Out	n/a
EPS (ttm)	-26.42
PE Ratio	n/a
Forward PE	n/a
Dividend	5.00 (0.65%)
Ex-Dividend Date	Jul 25, 2025

Volume	1,393
Average Volume	3,085
Open	779.80
Previous Close	768.60
Day's Range	768.70 - 779.80
52-Week Range	745.60 - 1,518.05
Beta	-0.03
RSI	42.31
Earnings Date	Feb 11, 2026

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1938
• Employees: 1,805
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ALBERTDAVD

Financial Performance

In 2024, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.